Hemophilia A: Emicizumab monitoring and impact on coagulation testing
{{output}}
Hemophilia A is an X-linked recessive bleeding disorder characterized by absent or ineffective coagulation factor VIII, a condition that could result in a severe and potentially life-threatening bleed. Although the current standard of care involves prophylacti... ...
